Fifth Third Bancorp
BBC icon

Fifth Third Bancorp’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Fifth Third Bancorp’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-200
Closed -$5K – 2181
2017
Q1 		$5K Hold
200
– – ﹤0.01% 1834
2016
Q4 		$4K Buy
+200
New +$3.99K ﹤0.01% 1951

Other funds holding BBC

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CCP
Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Fifth Third Bancorp's BBC Position: Q2 2017 in Review

Fifth Third Bancorp sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q2 2017, closing a stake of 200 shares — an estimated $5K sold.

Fifth Third Bancorp first reported a position in BBC in Q4 2016 and held it in 2 quarters. The position peaked at $5K in Q1 2017. 18 funds tracked by Wall St. Rank hold BBC as of Q2 2017.

  • Fifth Third Bancorp reported no remaining Virtus Biotech Clinical Trials ETF position as of Q2 2017 after selling out during the quarter.
  • Fifth Third Bancorp sold 200 Virtus Biotech Clinical Trials ETF shares in Q2 2017, an estimated $5K.
  • Fifth Third Bancorp first reported a position in Virtus Biotech Clinical Trials ETF in Q4 2016 and held it in 2 quarters.
  • Fifth Third Bancorp's Virtus Biotech Clinical Trials ETF position peaked at $5K in Q1 2017.
  • 18 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q2 2017.

Based on Fifth Third Bancorp's 13F filing for Q2 2017, filed 11 Aug 2017.